Duodenum Intestine-Chip for preclinical drug assessment in a human relevant model.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
14 01 2020
Historique:
received: 12 07 2019
accepted: 18 12 2019
entrez: 15 1 2020
pubmed: 15 1 2020
medline: 15 5 2021
Statut: epublish

Résumé

Induction of intestinal drug metabolizing enzymes can complicate the development of new drugs, owing to the potential to cause drug-drug interactions (DDIs) leading to changes in pharmacokinetics, safety and efficacy. The development of a human-relevant model of the adult intestine that accurately predicts CYP450 induction could help address this challenge as species differences preclude extrapolation from animals. Here, we combined organoids and Organs-on-Chips technology to create a human Duodenum Intestine-Chip that emulates intestinal tissue architecture and functions, that are relevant for the study of drug transport, metabolism, and DDI. Duodenum Intestine-Chip demonstrates the polarized cell architecture, intestinal barrier function, presence of specialized cell subpopulations, and

Identifiants

pubmed: 31933478
doi: 10.7554/eLife.50135
pii: 50135
pmc: PMC6959988
doi:
pii:

Substances chimiques

ABCB1 protein, human 0
ATP Binding Cassette Transporter, Subfamily B 0
Cytochrome P-450 CYP3A EC 1.14.14.1
CYP3A4 protein, human EC 1.14.14.55

Banques de données

GEO
['GSE135196']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK089502
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK116352
Pays : United States
Organisme : NIDDK NIH HHS
ID : R24 DK099803
Pays : United States

Informations de copyright

© 2020, Kasendra et al.

Déclaration de conflit d'intérêts

MK, RL, DM, GK, CL, JS, AA, JO, KJ, GH, KK is an employee and shareholder of Emulate, JY, LS, MD No competing interests declared

Références

Adv Drug Deliv Rev. 2013 Oct;65(10):1340-56
pubmed: 23041352
J Anat. 2008 Jun;212(6):879-86
pubmed: 18510513
Drug Metab Rev. 2011 Nov;43(4):476-98
pubmed: 21859377
Nat Med. 2013 Jul;19(7):939-45
pubmed: 23727931
Expert Opin Drug Metab Toxicol. 2008 Apr;4(4):395-411
pubmed: 18433344
Nature. 2013 Nov 14;503(7475):272-6
pubmed: 24089213
Br J Pharmacol. 2012 Mar;165(5):1260-87
pubmed: 22013971
Cell Signal. 2009 Aug;21(8):1237-44
pubmed: 19249356
Assay Drug Dev Technol. 2015 Jun;13(5):262-5
pubmed: 26121065
Fundam Clin Pharmacol. 2007 Dec;21(6):659-63
pubmed: 18034668
Nature. 2015 Jun 11;522(7555):173-8
pubmed: 26040716
Curr Drug Metab. 2014;15(10):915-41
pubmed: 25828591
Pharmacogenetics. 2004 Jan;14(1):1-18
pubmed: 15128046
Expert Opin Drug Metab Toxicol. 2006 Dec;2(6):875-94
pubmed: 17125407
Biomicrofluidics. 2016 Nov 01;10(6):064101
pubmed: 27822333
Drug Metab Dispos. 2018 Sep;46(9):1361-1371
pubmed: 29759961
Nature. 2009 May 14;459(7244):262-5
pubmed: 19329995
Nat Cell Biol. 2016 Mar;18(3):246-54
pubmed: 26911908
Gastroenterology. 2011 Nov;141(5):1762-72
pubmed: 21889923
Drug Metab Dispos. 2006 May;34(5):880-6
pubmed: 16467132
Drug Metab Dispos. 2016 Mar;44(3):476-80
pubmed: 26842595
PLoS Comput Biol. 2007 Mar 23;3(3):e39
pubmed: 17381235
Nat Protoc. 2013 Aug;8(8):1551-66
pubmed: 23868073
JCI Insight. 2016 Jun 2;1(8):e86907
pubmed: 27699268
Biochem Pharmacol. 2012 Jan 15;83(2):279-85
pubmed: 22062654
Stem Cell Reports. 2015 Jun 3;:null
pubmed: 26050928
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Integr Biol (Camb). 2013 Sep;5(9):1130-40
pubmed: 23817533
Nat Genet. 2000 May;25(1):25-9
pubmed: 10802651
J Clin Invest. 2007 Nov;117(11):3173-6
pubmed: 17975661
Nature. 2007 Jul 26;448(7152):427-34
pubmed: 17653185
Front Pharmacol. 2016 Sep 22;7:334
pubmed: 27713700
BMC Bioinformatics. 2018 Nov 14;19(1):423
pubmed: 30428853
Basic Clin Pharmacol Toxicol. 2017 Mar;120(3):250-255
pubmed: 27657920
Cell. 2015 May 7;161(4):933-45
pubmed: 25957691
Sci Rep. 2018 Feb 13;8(1):2871
pubmed: 29440725
Gut. 2003 Dec;52(12):1788-95
pubmed: 14633964
PLoS One. 2011;6(7):e21800
pubmed: 21789182
Drug Metab Dispos. 2008 Mar;36(3):604-13
pubmed: 18094037
Lab Chip. 2012 Jun 21;12(12):2165-74
pubmed: 22434367
Pharm Res. 2002 Oct;19(10):1400-16
pubmed: 12425456
Front Biosci. 1999 Mar 15;4:D286-98
pubmed: 10077541
Sci Rep. 2015 Nov 12;5:16479
pubmed: 26559489
Chem Biol Interact. 2001 May 16;134(3):283-9
pubmed: 11336976
J Pharm Biomed Anal. 2013 Nov;85:253-61
pubmed: 23973632
Drug Deliv. 2017 Nov;24(1):1453-1459
pubmed: 28949254
J Pharm Sci. 2016 Feb;105(2):817-827
pubmed: 26869432
Drug Metab Dispos. 2003 Dec;31(12):1507-19
pubmed: 14625347
Curr Drug Metab. 2008 Nov;9(9):893-900
pubmed: 18991586
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
Mol Pharmacol. 1997 May;51(5):741-54
pubmed: 9145912
Nucleic Acids Res. 2017 Jan 4;45(D1):D331-D338
pubmed: 27899567
Nat Protoc. 2013 Nov;8(11):2135-57
pubmed: 24113786
Chem Res Toxicol. 2008 Jan;21(1):70-83
pubmed: 18052394
Pharm Res. 2009 Sep;26(9):2039-54
pubmed: 19568696
J Biol Chem. 2003 May 9;278(19):17277-83
pubmed: 12611900
Nature. 2011 Jun 15;474(7351):307-17
pubmed: 21677747
Biochem Biophys Res Commun. 2016 Apr 15;472(4):631-6
pubmed: 26966071
Clin Res Regul Aff. 2015;32(2):47-56
pubmed: 26401094
J Basic Clin Pharm. 2010 Mar;1(2):63-9
pubmed: 24825967
Genome Res. 2003 Sep;13(9):2129-41
pubmed: 12952881
Cell Stem Cell. 2019 Jun 6;24(6):995-1005.e6
pubmed: 31173718
Clin Pharmacokinet. 2016 Jun;55(6):673-96
pubmed: 26895020
Science. 2018 Feb 23;359(6378):920-926
pubmed: 29472484
Cell. 1998 Jan 9;92(1):73-82
pubmed: 9489701

Auteurs

Magdalena Kasendra (M)

Emulate Inc, Boston, United States.

Raymond Luc (R)

Emulate Inc, Boston, United States.

Jianyi Yin (J)

Department of Medicine, Division of Gastroenterology, Johns Hopkins University School of Medicine, Baltimore, United States.

Dimitris V Manatakis (DV)

Emulate Inc, Boston, United States.

Gauri Kulkarni (G)

Emulate Inc, Boston, United States.

Carolina Lucchesi (C)

Emulate Inc, Boston, United States.

Josiah Sliz (J)

Emulate Inc, Boston, United States.

Athanasia Apostolou (A)

Emulate Inc, Boston, United States.
Graduate Program, Department of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Laxmi Sunuwar (L)

Department of Medicine, Division of Gastroenterology, Johns Hopkins University School of Medicine, Baltimore, United States.

Jenifer Obrigewitch (J)

Emulate Inc, Boston, United States.

Kyung-Jin Jang (KJ)

Emulate Inc, Boston, United States.

Geraldine A Hamilton (GA)

Emulate Inc, Boston, United States.

Mark Donowitz (M)

Department of Medicine, Division of Gastroenterology, Johns Hopkins University School of Medicine, Baltimore, United States.

Katia Karalis (K)

Emulate Inc, Boston, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH